Skip to main content

Market Overview

US Stock Futures Flat Ahead Of Pending Home Sales

US Stock Futures Flat Ahead Of Pending Home Sales

Pre-open movers

US stock futures were mostly flat in early pre-market trade, ahead of pending home sales data. The pending home sales index for July will be released at 10:00 a.m. ET. Futures for the Dow Jones Industrial Average dropped 1 point to 14,757.00, while the Standard & Poor's 500 index futures rose 0.30 points to 1,628.50. Futures for the Nasdaq 100 index increased 3 points to 3,062.50.

A Peek Into Global Markets

European markets were lower today, with the Spanish Ibex Index dropping 0.87%, London's FTSE 100 index falling 0.36% and STOXX Europe 600 Index declining 0.68%. German DAX 30 index fell 1.03% and French CAC 40 Index declined 0.28%.

Asian markets ended mostly lower today. China's Shanghai Composite fell 0.11%, while Japan's Nikkei Stock Average dropped 1.51%. Australia's ASX/S&P500 dropped 1.03%, Hong Kong's Hang Seng Index fell 1.60% and India's Sensex rose 0.16%.

Broker Recommendation

Analysts at JP Morgan downgraded TASER International (NASDAQ: TASR) from “overweight” to “neutral.” The target price for TASER International is set to $12.

TASER's shares closed at $11.85 yesterday.

Breaking news

  • Joy Global (NYSE: JOY) reported upbeat fiscal third-quarter earnings. Joy Global's quarterly profit fell to $183.2 million, or $1.71 per share, from $193.5 million, or $1.81 per share, in the year-ago period. To read the full news, click here.
  • IMAX Corporation (NYSE: IMAX) and Cineworld Group PLC, the UK's largest cinema chain, today announced an expansion of the companies' revenue sharing agreement with an IMAX theatre to be added at a location yet to be determined and the installation of IMAX's next-generation laser digital projection technology at Glasgow Science Centre's IMAX® theatre in Scotland. To read the full news, click here.
  • Seadrill (NYSE: SDRL) reported a surge in its second-quarter net profit. Seadrill's quarterly net profit jumped to $1.73 billion, or $3.68 per share. To read the full news, click here.
  • Simcere Pharmaceutical Group (NYSE: SCR) announced today that it has entered into a definitive Agreement and Plan of Merger with Simcere Holding Limited and Simcere Acquisition Limited, pursuant to which Parent will acquire Simcere for US$4.83 per ordinary share of the Company or US$9.66 per American depositary share, each representing two Shares. To read the full news, click here.

Related Articles (TASR + JOY)

View Comments and Join the Discussion!

Posted-In: JP Morgan US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at